Ipca Laboratories Ltd. — Board/Management Information 2022

Oct 20, 2022

THRU ONLINE FILING

October 20, 2022

BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 023 Scrip Code – 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra – (East). Mumbai-400051. Scrip Code : IPCALAB

Dear Sirs,

Re : Outcome of Board Meeting held on 20th October, 2022

1. The Board has appointed Dr. Narendra Mairpady (DIN 00536905) as an Additional Director of the Company with effect from 20th October, 2022. He is also appointed as an Independent Director of the Company for a period of 5 years from 20th October, 2022 till 19th October, 2027. This appointment is subject to the approval of shareholders.

Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 of Independent Director appointed:

Name : Dr. Narendra Mairpady (DIN 00536905)
1.	Reason for Change	Appointed as an Additional/Independent Director ofthe Company with effect from 20th October, 2022.
2.	Date of appointment &term of appointment	For a period of 5 years from 20th October, 2022 till19th October, 2027.
3.	Brief Profile (in case ofappointment)	Dr. Narendra Mairpady, aged 68 years, is aCommerce Graduate and also holds a Bachelor ofLaw Degree from Mysore University. He is also acertified CAIIB from the Institure of Banking. HehasalsoobtainedhisDoctorLettersfromHindustanUniversity,ChennaiandKalpagamUniversity, Coimbatore.
		Dr. Narendra Mairpady has nearly 4 decades ofbanking experience. He joined Corporation Bankas a Trainee Officer in the year 1975 and rose tothe position of Chief General Manager when hisservices were transferred as Executive Director ofBank of India in the year 2008. In the year 2010,he was appointed as the Chairman and ManagingDirector of Indian Overseas Bank from whichposition he retired in the year 2014.Dr.NarendraMairpadyisnotdebarred from
		holding the office of Director by virtue of any SEBIorder or order by any other competent authority.
4.	Disclosure of relationshipsbetween directors	Not related to any Director or Key ManagerialPersonnel of the Company.

1. Consequent to the above, the revised composition of the Board of Directors of the Company with effect from 20th October, 2022 will be :

Mr. Premchand Godha	Chairman & Managing Director / CEO
Mr. A.K. Jain	Joint Managing Director / CFO
Mr. Pranay Godha	Executive Director
Mr. Prashant Godha	Executive Director
Mr. Anand T. Kusre	Independent Director
Dr. (Ms.) Manisha Premnath	Independent Director
Mr. Kamal Kishore Seth	Independent Director
Dr. Narendra Mairpady	Independent Director

1. The Board has also re-constituted its following committees with effect from 20th October, 2022 and the revised Board Committees will now comprise of the following Board Members:

Audit Committee
Mr. Anand T. Kusre	Chairman of the Committee / Independent Director
Mr. Kamal Kishore Seth	Independent Director
Dr. Narendra Mairpady	Independent Director
Mr. Prashant Godha	Executive Director

Nomination and Remuneration Committee
Mr. Anand T. Kusre	Chairman of the Committee / Independent Director
Mr. Kamal Kishore Seth	Independent Director
Dr. (Ms.) Manisha Premnath	Independent Director
Dr. Narendra Mairpady	Independent Director

Kindly note that the Board meeting started at 10.15 a.m. and concluded at 10.50 a.m.

Thanking you

Yours faithfully For Ipca Laboratories Limited

Harish Pandurang Kamath Digitally signed by Harish Pandurang Kamath DN: c=IN, o=Personal, title=1715, pseudonym=3f7ac814d30fe4f87db4e251aafcbf81ab20003dc 8e02a91eb3d7c33065f5b40, postalCode=400091, st=Maharashtra, serialNumber=72050fb9fadcbc5de6404685117b8355792f578 4c7617d9c4cae2a3887d6b809, cn=Harish Pandurang Kamath Date: 2022.10.20 10:53:06 +05'30'

Harish P. Kamath Corporate Counsel & Company Secretary

lpca Laboratories Ltd. www.ipca.com 125, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India I T:+91 22 6210 5000 F:+91 22 62105005 Regd. Office:48, Kandivli Industrial Estate, Kandivli(West), Mumbai 400 067 (Maharashtra),India I T:+91 22 6647 4444 E: ipca@ipca.com CIN: L24239MH1949PLC007837